The global law firm Greenberg Traurig has announced the addition of Can Cui as a shareholder in its life sciences and medical technology practice based in Austin. Cui’s legal expertise is concentrated on technology transactions and investments within the life sciences industry, with a notable focus on cross-border deals involving Asia, particularly China.
Before joining Greenberg Traurig, Cui was a part of Goodwin, another prestigious legal firm known for its expertise in technology and life sciences sectors. His practice at Goodwin centered on technology licensing, acquisition, partnerships, and joint ventures. Cui’s skill set includes guiding clients through intricate dealings across international borders, which is becoming increasingly valuable in today’s global marketplace.
For its growth strategy, Greenberg Traurig has placed significant emphasis on expanding its presence in Texas. The appointment of Cui reflects the firm’s commitment to bolstering its capabilities in the life sciences and medical technology sectors. The announcement was made by the firm on Wednesday.
For more details on Can Cui’s appointment and Greenberg Traurig’s strategic expansions, visit Bloomberg Law.